Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
21.96
+0.86 (4.08%)
At close: Jul 3, 2026
-24.52% (1Y)
| Market Cap | 11.16B -15.0% |
| Revenue (ttm) | 679.75M -5.1% |
| Net Income | 25.67M -72.8% |
| EPS | 0.05 -70.9% |
| Shares Out | 508.22M |
| PE Ratio | 434.77 |
| Forward PE | n/a |
| Dividend | 0.04 (0.19%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 10,621,124 |
| Open | 21.09 |
| Previous Close | 21.10 |
| Day's Range | 21.09 - 22.08 |
| 52-Week Range | 17.52 - 35.22 |
| Beta | 0.29 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 18, 2026 |